112 related articles for article (PubMed ID: 29080681)
1. Uncoupling of ER/Mitochondrial Oxidative Stress in mTORC1 Hyperactivation-Associated Skin Hypopigmentation.
Yang F; Yang L; Wataya-Kaneda M; Yoshimura T; Tanemura A; Katayama I
J Invest Dermatol; 2018 Mar; 138(3):669-678. PubMed ID: 29080681
[TBL] [Abstract][Full Text] [Related]
2. Tuberous sclerosis complex inactivation disrupts melanogenesis via mTORC1 activation.
Cao J; Tyburczy ME; Moss J; Darling TN; Widlund HR; Kwiatkowski DJ
J Clin Invest; 2017 Jan; 127(1):349-364. PubMed ID: 27918305
[TBL] [Abstract][Full Text] [Related]
3. Dysregulation of autophagy in melanocytes contributes to hypopigmented macules in tuberous sclerosis complex.
Yang F; Yang L; Wataya-Kaneda M; Hasegawa J; Yoshimori T; Tanemura A; Tsuruta D; Katayama I
J Dermatol Sci; 2018 Feb; 89(2):155-164. PubMed ID: 29146131
[TBL] [Abstract][Full Text] [Related]
4. Ablation of TSC2 enhances insulin secretion by increasing the number of mitochondria through activation of mTORC1.
Koyanagi M; Asahara S; Matsuda T; Hashimoto N; Shigeyama Y; Shibutani Y; Kanno A; Fuchita M; Mikami T; Hosooka T; Inoue H; Matsumoto M; Koike M; Uchiyama Y; Noda T; Seino S; Kasuga M; Kido Y
PLoS One; 2011; 6(8):e23238. PubMed ID: 21886784
[TBL] [Abstract][Full Text] [Related]
5. Novel mTORC1 Mechanism Suggests Therapeutic Targets for COMPopathies.
Posey KL; Coustry F; Veerisetty AC; Hossain MG; Gambello MJ; Hecht JT
Am J Pathol; 2019 Jan; 189(1):132-146. PubMed ID: 30553437
[TBL] [Abstract][Full Text] [Related]
6. Cartilage Ablation of Sirt1 Causes Inhibition of Growth Plate Chondrogenesis by Hyperactivation of mTORC1 Signaling.
Jin X; Kang X; Zhao L; Xu M; Xie T; Li H; Li F; Qian Z; Ma Z; Zhang Y; Yang W; Zhang Z; Gao X; Chen Q; Sun H; Wu S
Endocrinology; 2019 Dec; 160(12):3001-3017. PubMed ID: 31599935
[TBL] [Abstract][Full Text] [Related]
7. Epilepsy in a melanocyte-lineage mTOR hyperactivation mouse model: A novel epilepsy model.
Yang F; Yang L; Wataya-Kaneda M; Teng L; Katayama I
PLoS One; 2020; 15(1):e0228204. PubMed ID: 31978189
[TBL] [Abstract][Full Text] [Related]
8. Mammalian target of rapamycin and tuberous sclerosis complex.
Wataya-Kaneda M
J Dermatol Sci; 2015 Aug; 79(2):93-100. PubMed ID: 26051878
[TBL] [Abstract][Full Text] [Related]
9. mTORC1-Driven Tumor Cells Are Highly Sensitive to Therapeutic Targeting by Antagonists of Oxidative Stress.
Li J; Shin S; Sun Y; Yoon SO; Li C; Zhang E; Yu J; Zhang J; Blenis J
Cancer Res; 2016 Aug; 76(16):4816-27. PubMed ID: 27197195
[TBL] [Abstract][Full Text] [Related]
10. Regulation of Small Intestinal Epithelial Homeostasis by Tsc2-mTORC1 Signaling.
Setiawan J; Kotani T; Konno T; Saito Y; Murata Y; Noda T; Matozaki T
Kobe J Med Sci; 2019 Apr; 64(6):E200-E209. PubMed ID: 31327863
[TBL] [Abstract][Full Text] [Related]
11. Clinical and Histologic Analysis of the Efficacy of Topical Rapamycin Therapy Against Hypomelanotic Macules in Tuberous Sclerosis Complex.
Wataya-Kaneda M; Tanaka M; Yang L; Yang F; Tsuruta D; Nakamura A; Matsumoto S; Hamasaki T; Tanemura A; Katayama I
JAMA Dermatol; 2015 Jul; 151(7):722-30. PubMed ID: 25692384
[TBL] [Abstract][Full Text] [Related]
12. Regulation of colonic epithelial cell homeostasis by mTORC1.
Kotani T; Setiawan J; Konno T; Ihara N; Okamoto S; Saito Y; Murata Y; Noda T; Matozaki T
Sci Rep; 2020 Aug; 10(1):13810. PubMed ID: 32796887
[TBL] [Abstract][Full Text] [Related]
13. Hyperactivation of mTORC1 disrupts cellular homeostasis in cerebellar Purkinje cells.
Sakai Y; Kassai H; Nakayama H; Fukaya M; Maeda T; Nakao K; Hashimoto K; Sakagami H; Kano M; Aiba A
Sci Rep; 2019 Feb; 9(1):2799. PubMed ID: 30808980
[TBL] [Abstract][Full Text] [Related]
14. mTOR Hyperactivation by Ablation of Tuberous Sclerosis Complex 2 in the Mouse Heart Induces Cardiac Dysfunction with the Increased Number of Small Mitochondria Mediated through the Down-Regulation of Autophagy.
Taneike M; Nishida K; Omiya S; Zarrinpashneh E; Misaka T; Kitazume-Taneike R; Austin R; Takaoka M; Yamaguchi O; Gambello MJ; Shah AM; Otsu K
PLoS One; 2016; 11(3):e0152628. PubMed ID: 27023784
[TBL] [Abstract][Full Text] [Related]
15. The biology of pigmentation.
Fitzpatrick TB
Birth Defects Orig Artic Ser; 1971 Jun; 7(8):5-12. PubMed ID: 5006148
[TBL] [Abstract][Full Text] [Related]
16. mTORC1 activation downregulates FGFR3 and PTH/PTHrP receptor in articular chondrocytes to initiate osteoarthritis.
Zhang H; Wang H; Zeng C; Yan B; Ouyang J; Liu X; Sun Q; Zhao C; Fang H; Pan J; Xie D; Yang J; Zhang T; Bai X; Cai D
Osteoarthritis Cartilage; 2017 Jun; 25(6):952-963. PubMed ID: 28043938
[TBL] [Abstract][Full Text] [Related]
17. IL-4 inhibits the melanogenesis of normal human melanocytes through the JAK2-STAT6 signaling pathway.
Choi H; Choi H; Han J; Jin SH; Park JY; Shin DW; Lee TR; Kim K; Lee AY; Noh M
J Invest Dermatol; 2013 Feb; 133(2):528-36. PubMed ID: 22992805
[TBL] [Abstract][Full Text] [Related]
18. mTORC1-mediated downregulation of COX2 restrains tumor growth caused by TSC2 deficiency.
Li H; Jin F; Jiang K; Ji S; Wang L; Ni Z; Chen X; Hu Z; Zhang H; Liu Y; Qin Y; Zha X
Oncotarget; 2016 May; 7(19):28435-47. PubMed ID: 27078846
[TBL] [Abstract][Full Text] [Related]
19. Prolonging the survival of Tsc2 conditional knockout mice by glutamine supplementation.
Rozas NS; Redell JB; McKenna J; Moore AN; Gambello MJ; Dash PK
Biochem Biophys Res Commun; 2015 Feb; 457(4):635-9. PubMed ID: 25613864
[TBL] [Abstract][Full Text] [Related]
20. Endothelial deletion of mTORC1 protects against hindlimb ischemia in diabetic mice via activation of autophagy, attenuation of oxidative stress and alleviation of inflammation.
Fan W; Han D; Sun Z; Ma S; Gao L; Chen J; Li X; Li X; Fan M; Li C; Hu D; Wang Y; Cao F
Free Radic Biol Med; 2017 Jul; 108():725-740. PubMed ID: 28473248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
